At Mayuri Vaccines & Biologicals, we are dedicated to advancing healthcare through the manufacturing of high-quality pharmaceuticals, medicinal chemicals, and botanical products. With a steadfast commitment to innovation, quality, and sustainability, we aim to make a lasting impact on global health.

Contact Info CTS # 16/4757/B, SHIGGAON PARK (SHIRUR PARK) VIDYANAGAR HUBBALLI-580021 (KARANATAKA) CITY & PIN CODE HUBBALLI- 580021 08362335270 / +919448144550 info@mayurivaccines.com

Please enter subscribe form shortcode

Mayuri Vaccines & Biologicals

Founded in July 2007, Mayuri Vaccines & Biologicals embarked on a journey dedicated to revolutionizing healthcare solutions. Beginning with trading in Renal care, Critical care, Vaccines, and Surgicals, we quickly earned recognition for our commitment to excellence and unparalleled infrastructure.

Our dedication to quality attracted the attention of industry leaders like Baxter India Pvt Ltd, who appointed us as their exclusive Channel partner for North Karnataka. Since then, we have solidified our position as a leader in sales and services of Renal Care, setting new benchmarks in the industry.

As authorized Channel partners for renowned companies including Baxter, Biocon, Bharat Serum,Takeda Biopharmaceuticals India Private Limited,Serum Institute of India Pvt.Ltd.Browndove, Poly Medicure Ltd,Coloplast,Trivitron Healthcare,Centaur Pharmaceuticals, Medtronic, Fresenius Kabi, and many others, we ensure seamless distribution of life-saving pharmaceutical products.

Located behind the Hubballi International Airport in the Gamanagatti Industrial area, our manufacturing unit boasts extensive premises and state-of-the-art facilities. In September 2023, we inaugurated a cutting-edge testing laboratory, equipped with temperature-controlled environments to maintain product integrity.

Committed to environmental sustainability, we have implemented Rainwater harvesting units and an Effluent Treatment Plant (ETP), adhering to stringent guidelines set by the Pollution Control Board. Our ISO 13485 certification and KSPCB certification underscore our unwavering commitment to quality and compliance.

At Mayuri Vaccines & Biologicals, quality assurance is paramount. Our in-house laboratories are equipped with the latest technology for General and Microbiology testing, ensuring each product meets the highest standards of safety and efficacy. Our microbiology lab is meticulously maintained, with Hepa filters and instruments like laminar airflow systems to minimize contamination risks.

With a vast, ambient temperature-controlled storage area, we ensure optimal conditions for storing our products, preserving their efficacy until they reach those who need them most.

Join us as we continue to innovate, elevate, and transform healthcare delivery, one product at a time.

Healthcare Solutions Provider


Hemodialysis Concentrate Manufacturing:

"Mayuri Vaccines and Biologicals excels in producing premium Hemodialysis Concentrate, prioritizing stringent standards for utmost safety and efficacy in renal care."

Renal Care Solutions:

"Our skilled team excels in delivering comprehensive renal care solutions, serving as authorized vendors in prominent hospitals across Karnataka. Prioritizing critical care management ensures optimal patient outcomes."

Critical Care Products:

"Mayuri Vaccines and Biologicals provides essential critical care products for hospitals, meticulously managing the cold chain to ensure the precise and reliable handling and supply of these critical items. Our commitment to excellence is evident in our dedication to maintaining optimal conditions throughout the cold chain process."

Surgical Products:

"Mayuri Vaccines and Biologicals delivers top-tier surgical solutions, enhancing healthcare outcomes through expertise in surgical products. Our commitment to excellence permeates every aspect of our operations."


Years of Experience

We’ll Ensure You Alwasy Get Best Results.

Read our MIssion & Vission
  • Hemodialysis Concentrate Manufacturing:
  • Renal Care Solutions:
  • Critical Care Products:
  • Surgical Products:
Infrastructure Development and Certifications (2021-2023):
Infrastructure Development and Certifications (2021-2023): 70%
Continuous Innovation and Future Endeavors (2024-Present):
Continuous Innovation and Future Endeavors (2024-Present): 100%
Partnerships and Authorized Vendor Status (2016-2020):
Partnerships and Authorized Vendor Status (2016-2020): 85%